GlassScriptPhysician profile
Ashlyn H Fields
NPI 1982248233
$1,213.96
in general payments reported to CMS, 2019-2025
18 companies · $64.42 in 2025
The $64.42 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $542 · 2022: $536 · 2023: $34.38 · 2024: $37.22 · 2025: $64.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $136.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $305.89 | 2021-2025 | |
| Ucb, INC. | $199.50 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $134.29 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $95.99 | 2021-2022 | |
| Sk Life Science, INC. | $83.28 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $60.34 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.37 | 2021-2022 | |
| Adamas Pharmaceuticals, INC. | $44.58 | 2021 | |
| Medtronic, INC. | $42.30 | 2021-2024 | Intellis Adaptivestim |
| Tanabe Pharma America, INC. | $31.25 | 2021-2022 | |
| Greenwich Biosciences, INC. | $27.00 | 2021 | |
| Sunovion Pharmaceuticals INC. | $26.39 | 2021 | |
| Bioventus LLC | $22.43 | 2022 | |
| Alexion Pharmaceuticals, INC. | $22.17 | 2021 | |
| Jazz Pharmaceuticals INC. | $19.03 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $14.80 | 2021 | |
| Collegium Pharmaceutical, INC. | $13.30 | 2021 | |
| Biogen, INC. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashlyn Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.